Although only six months have passed since the isolation of the gene for Huntington's disease (HD) and the recognition of the mutation involved, there has already been an explosion of work on this subject, much of which is reported in the series of papers in this issue of Journal of Medical Genetics. As the title of this review implies, most of the work relates to the properties of the HD mutation rather than to the nature and function of the gene itself.
The original HD Collaborative Research Group report' gave details of the size of the gene, termed IT15, which has a cDNA of 10 366 bases, and of the predicted protein (provisionally named huntingtin), estimated to contain 3144 amino acids with a molecular weight of 348 kDa. The amino acid sequence has shown no similarities with any known protein and there is no clear indication of its likely structure and function. Little further information has as yet emerged, either in publications or in presentations at the recent international workshop on HD.2 The gene contains 67 exons and shows universal expression in different body tissues, including neurones and glial cells, with no obvious differences in different regions of the brain. Thus the full impact of the discovery on our understanding of the neurobiology and pathology of the disease still lies in the future, though rapid progress can be anticipated.
By contrast, our understanding of the HD mutation and its relationship to the genetics and phenotype of the disorder has increased dramatically, in a manner comparable to that seen in myotonic dystrophy and fragile X mental retardation, also the result of trinucleotide repeat expansions, and each the subject of collections of papers in this journal one The initial finding of an inverse correlation between CAG repeat size and age at onset of HD has been conclusively confirmed by subsequent reports, both those already published5-7 and by the reports from The Netherlands," Scotland,'2 and England'3 in this issue. The different studies agree in finding the largest expansions and strongest age at onset correlation in the rare juvenile cases. By comparison with congenital myotonic dystrophy the expansions in this group are less extreme, rarely exceeding 100 repeats in juvenile HD, but it is interesting that both disorders show a strong parent of origin effect, juvenile HD cases being mostly paternal in origin, while cases of congenital myotonic dystrophy are almost exclusively maternal. Outside these extreme groups, the age at onset correlation persists, and is indeed seen in the series of 133 HD patients with onset after 50 years reported here.'4 However, the range of onset for any given result appears to be too great to allow any specific conclusions in subjects seen for presymptomatic testing,' though the finding of a small expansion in a relative at risk may suggest that a later onset is most likely.'3 Somatic instability of the mutation has been a striking feature of the trinucleotide repeat mutations in both fragile X'5 and myotonic dystrophy,'6" 7but data reported here'8 show that this is not a major feature in HD, with close correspondence between the findings in blood and brain, and with no change in time between stored lymphoblasts and fresh blood. Similarly, identical twin pairs show similar repeat lengths,'8 suggesting that most instability is prezygotic in origin. Two generation data are less frequent in HD than for the other disorders' 7 but confirm the previous observation of anticipation, especially in the male line,'9 though the repeat sequence may decrease in size as well as expand. 
